We are live on
!
Find out more
BM
Bridger Management Portfolio holdings
AUM
$128M
1-Year Est. Return
9.54%
This Fund
S&P 500
This Quarter
Est. Return
+12.01%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$1.73B
AUM Growth
-$117M
(-6.4%)
Cap. Flow
-$251M
Cap. Flow
% of AUM
-14.51%
Top 10 Holdings %
Top 10 Hldgs %
49.08%
Holding
42
New
5
Increased
7
Reduced
8
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FDC
First Data Corporation
FDC
|
+$64.1M |
| 2 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
+$33.5M |
| 3 |
CZR
Caesars Entertainment Corporation
CZR
|
+$30.8M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$27.3M |
| 5 |
Ironwood Pharmaceuticals
IRWD
|
+$11.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$65.7M |
| 2 |
Humana
HUM
|
+$62.9M |
| 3 |
Labcorp
LH
|
+$61.2M |
| 4 |
Armstrong World Industries
AWI
|
+$48.6M |
| 5 |
SGI
Somnigroup International
SGI
|
+$44.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.82% |
| 2 | Technology | 10.42% |
| 3 | Consumer Discretionary | 9.27% |
| 4 | Communication Services | 7.46% |
| 5 | Consumer Staples | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
HCA Healthcare
HCA
$86.1B
| $110M | 6.35% |
789,399
-89,362
| -10% | -$11.1M |
|
2
Atara Biotherapeutics
ATRA
$72.5M
| $102M | 5.88% |
98,370
| – | – |
|
3
Zimmer Biomet
ZBH
$18B
| $92.7M | 5.36% |
726,297
+64,365
| +10% | +$7.65M |
|
4
GoDaddy
GDDY
$10.5B
| $92.3M | 5.34% |
1,106,900
-390,092
| -26% | -$30.5M |
|
5
Post Holdings
POST
$4.17B
| $90.8M | 5.25% |
1,414,595
-316,643
| -18% | -$19.4M |
|
|
DRNA
6
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $84.4M | 4.88% |
5,530,028
+2,304,501
| +71% | +$33.5M |
|
7
Heron Therapeutics
HRTX
$93.8M
| $72.5M | 4.19% |
2,290,064
+292,367
| +15% | +$10.9M |
|
|
MDCO
8
DELISTED
Medicines Co
MDCO
| $70M | 4.05% |
2,339,690
-265,275
| -10% | -$9.99M |
|
9
Nektar Therapeutics
NKTR
$2.37B
| $69.2M | 4% |
75,628
| – | – |
|
|
FDC
10
DELISTED
First Data Corporation
FDC
| $65.1M | 3.76% |
+2,658,994
| New | +$64.1M |
|
|
WMGI
11
DELISTED
Wright Medical Group Inc
WMGI
| $64.5M | 3.73% |
2,223,257
-307,988
| -12% | -$8.3M |
|
12
Alnylam Pharmaceuticals
ALNY
$27.3B
| $63.3M | 3.66% |
723,010
+80,544
| +13% | +$8.1M |
|
13
Charter Communications
CHTR
$17.3B
| $61.3M | 3.55% |
188,164
| – | – |
|
14
Amneal Pharmaceuticals
AMRX
$5.76B
| $58.6M | 3.39% |
2,642,621
+499,000
| +23% | +$10.5M |
|
15
DexCom
DXCM
$31.9B
| $57.1M | 3.3% |
1,596,916
-1,087,104
| -41% | -$33.7M |
|
16
MGM Resorts International
MGM
$11.4B
| $54.5M | 3.15% |
1,952,772
+238,580
| +14% | +$6.92M |
|
17
Caesars Entertainment
CZR
$6.05B
| $54.1M | 3.13% |
1,112,836
-566,182
| -34% | -$25.7M |
|
18
Morgan Stanley
MS
$334B
| $53.2M | 3.08% |
1,143,109
| – | – |
|
19
Rocket Pharmaceuticals
RCKT
$336M
| $43.2M | 2.5% |
1,752,902
| – | – |
|
20
Viasat
VSAT
$10.6B
| $36.5M | 2.11% |
570,979
| – | – |
|
|
MSGN
21
DELISTED
MSG Networks Inc.
MSGN
| $34.7M | 2.01% |
1,346,056
| – | – |
|
22
Liberty Broadband Class A
LBRDA
$4.88B
| $32.9M | 1.9% |
390,292
| – | – |
|
23
Teva Pharmaceuticals
TEVA
$40.6B
| $32.3M | 1.87% |
1,500,000
| – | – |
|
|
CZR
24
DELISTED
Caesars Entertainment Corporation
CZR
| $30M | 1.74% |
+2,930,541
| New | +$30.8M |
|
|
ATVI
25
DELISTED
Activision Blizzard
ATVI
| $29.9M | 1.73% |
+360,000
| New | +$27.3M |
|
Similar funds
SHFC
IUC
PC
SIM
PIA
S
CF
BC
Bridger Management's Q3 2018 Portfolio in Review
As of Q3 2018, Bridger Management held 42 positions worth $1.73B, down 6.4% from $1.85B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Bridger Management withdrew a net $251M in Q3 2018, closing 8 positions and reducing 8 holdings. Its most notable exit was Wellcare Health Plans, Inc., an estimated $65.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 46% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Bridger Management opened a new position in First Data Corporation worth $65.1M.
- Bridger Management's largest Q3 2018 buy was First Data Corporation: 2,658,994 shares worth $65.1M.
- Bridger Management added most to Dicerna Pharmaceuticals, Inc. in Q3 2018, an estimated $33.5M increase.
- Bridger Management's biggest Q3 2018 reduction was DexCom, cutting an estimated $33.7M.
- Bridger Management fully exited Wellcare Health Plans, Inc. in Q3 2018, selling an estimated $65.7M.
- Bridger Management's ten largest holdings make up 49% of its $1.73B portfolio in Q3 2018.
- Bridger Management opened 5 new positions and closed 8 in Q3 2018.
- Bridger Management's portfolio value fell 6.4% quarter-over-quarter to $1.73B.
Based on Bridger Management's 13F filing for Q3 2018, filed 14 Nov 2018.